Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Skuli

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Oncotarget|March 1, 2018
Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumorsJoshua Casaos, Sakibul Huq, Tarik Lott, et al.
Hepatology (Baltimore, Md.)|April 30, 2026
Locoregional lactate dehydrogenase inhibition potentiates therapy and overcomes treatment resistance in hepatocellular carcinomaDaniel J Boehmler, Ryan J Baron, Jennifer A Brain, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Inhibiting Glycan Degradation Prevents HIV-Induced Inflammaging and Cognitive ImpairmentLeila B Giron, Alejandra Borjabad, Eran Hadas, et al.
The Journal of Clinical Investigation|April 23, 2024
Oncogene-induced matrix reorganization controls CD8+ T cell function in the soft-tissue sarcoma microenvironmentAshley M Fuller, Hawley C Pruitt, Ying Liu, et al.
Med (New York, N.Y.)|June 5, 2026
Inhibiting glycan degradation prevents HIV-induced inflammaging and cognitive impairmentLeila B Giron, Alejandra Borjabad, Eran Hadas, et al.
Leukemia|July 9, 2025
Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress responseSarah J Skuli, A'ishah Bakayoko, Marisa Kruidenier, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Oncotarget|March 1, 2018
Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumorsJoshua Casaos, Sakibul Huq, Tarik Lott, et al.
Hepatology (Baltimore, Md.)|April 30, 2026
Locoregional lactate dehydrogenase inhibition potentiates therapy and overcomes treatment resistance in hepatocellular carcinomaDaniel J Boehmler, Ryan J Baron, Jennifer A Brain, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Inhibiting Glycan Degradation Prevents HIV-Induced Inflammaging and Cognitive ImpairmentLeila B Giron, Alejandra Borjabad, Eran Hadas, et al.
The Journal of Clinical Investigation|April 23, 2024
Oncogene-induced matrix reorganization controls CD8+ T cell function in the soft-tissue sarcoma microenvironmentAshley M Fuller, Hawley C Pruitt, Ying Liu, et al.
Med (New York, N.Y.)|June 5, 2026
Inhibiting glycan degradation prevents HIV-induced inflammaging and cognitive impairmentLeila B Giron, Alejandra Borjabad, Eran Hadas, et al.
Leukemia|July 9, 2025
Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress responseSarah J Skuli, A'ishah Bakayoko, Marisa Kruidenier, et al.
Pageof 7